Methylphenidate hydrochloride and Abortion spontaneous - a phase IV clinical study of FDA data
Summary:
Abortion spontaneous is reported as a side effect among people who take Methylphenidate hydrochloride (methylphenidate hydrochloride), especially for people who are 40-49 old, also take Alcohol, and have Drowsiness.
The phase IV clinical study analyzes which people have Abortion spontaneous when taking Methylphenidate hydrochloride. It is created by eHealthMe based on reports of 6,364 people who have side effects when taking Methylphenidate hydrochloride from the FDA, and is updated regularly.
What is Methylphenidate hydrochloride?
Methylphenidate hydrochloride has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 6,822 Methylphenidate hydrochloride users. Check the latest studies of Methylphenidate hydrochloride.
What is Abortion spontaneous?
Abortion spontaneous (naturally occurring miscarriage) is found to be associated with 1,008 drugs and 1,279 conditions by eHealthMe. Check the latest studies of Abortion spontaneous.
6,364 people reported to have side effects when taking Methylphenidate hydrochloride.
Among them, 13 people (0.2%) have Abortion spontaneous.
Among these 13 people:
What is the age of people who have Abortion spontaneous when taking Methylphenidate hydrochloride? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 20 %
- 30-39: 40 %
- 40-49: 40 %
- 50-59: 0.0 %
- 60+: 0.0 %
What are other drugs people take besides Methylphenidate hydrochloride? *
- Pregabalin: 3 people, 23.08%
- Diazepam: 3 people, 23.08%
- Buprenorphine: 3 people, 23.08%
- Alcohol: 3 people, 23.08%
- Lamictal: 2 people, 15.38%
- Keppra: 2 people, 15.38%
- Atomoxetine: 2 people, 15.38%
- Xyrem: 1 person, 7.69%
- Sunosi: 1 person, 7.69%
- Modafinil: 1 person, 7.69%
What are other side effects people have besides Abortion spontaneous? *
- Maternal Exposure During Pregnancy (use of substance during pregnancy): 4 people, 30.77%
- Vaginal Bleeding: 3 people, 23.08%
- Premature Baby: 2 people, 15.38%
- Premature Labor: 1 person, 7.69%
- Initial Insomnia (feeling of inadequate or poor-quality sleep): 1 person, 7.69%
- Drug Ineffective: 1 person, 7.69%
- Birth Control: 1 person, 7.69%
- Abortion Induced (medically referred abortion): 1 person, 7.69%
What are the existing conditions these people have? *
- Drowsiness: 3 people, 23.08%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 15.38%
- Iron Deficiency: 1 person, 7.69%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.69%
- Depression: 1 person, 7.69%
- Birth Control: 1 person, 7.69%
- Asthma: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Methylphenidate hydrochloride and have Abortion spontaneous?
- Check whether Abortion spontaneous is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Methylphenidate hydrochloride:
- Methylphenidate hydrochloride (6,822 reports)
Abortion spontaneous treatments and more:
- Abortion spontaneous (45,712 reports)
How severe was Abortion spontaneous and when was it recovered:
Expand to all the drugs that have ingredients of methylphenidate hydrochloride:
Sub-studies by age:
0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methylphenidate hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Abortion spontaneous:
- Abortion spontaneous (1,008 drugs)
Browse all the conditions that are associated with Abortion spontaneous:
- Abortion spontaneous (1,279 conditions)
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Methylphenidate hydrochloride) and Methylphenidate hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Inflammation and Generalized Anxiety Disorder - 4 seconds ago
- Drug interactions of Lisinopril and Quillivant Xr - 5 seconds ago
- Could Lamictal cause Hydrocephalus? - 8 seconds ago
- Could Fluorouracil cause Paroxysmal Supraventricular Tachycardia? - 17 seconds ago
- Could Sensipar cause Weight Decreased? - 26 seconds ago
- Drug interactions of Adalat and Movicol - 30 seconds ago
- Could Lumigan cause Coughing Up Blood? - 35 seconds ago
- Could Paxlovid cause Infusion Related Reaction? - 40 seconds ago
- Could Tavalisse cause Head Injury? - 56 seconds ago
- Drug interactions of Hydrochlorothiazide and Tylenol - 56 seconds ago